Browse by Phase
Phase 3 Clinical Trials
Phase 3 trials compare a new drug or treatment against the current standard of care in a large population (300–3,000+ participants). Successful Phase 3 results are the basis for regulatory approval.
Total Trials
514
Recruiting Now
514
Top Conditions in Phase 3
NCT06937229 Phase 3
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agi...
Condition
Alzheimer Disease
Enrollment
600 pts
Location
United States, Argentina, Brazil
Sponsor
Bristol-Myers Squibb
NCT06597019 Phase 3
Recruiting
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygou...
Condition
Familial Hypercholesterolemia - Heterozygous
Enrollment
51 pts
Location
United States, Argentina, Austria
Sponsor
Novartis Pharmaceuticals
NCT06713837 Phase 3
Recruiting
IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acu...
Condition
Acute Myeloid Leukemia
Enrollment
339 pts
Location
Czechia, Germany, Italy
Sponsor
Istituto Romagnolo per lo Stud
NCT07008365 Phase 3
Recruiting
The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decong...
Condition
Acute Heart Failure
Enrollment
168 pts
Location
Spain
Sponsor
Instituto de Investigación San
NCT05719467 Phase 3
Recruiting
SAINT: Safe Induction of Labor Trial
Condition
Labor Complication
Enrollment
3,000 pts
Location
Norway
Sponsor
Oslo University Hospital
NCT06947967 Phase 3
Recruiting
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymph...
Condition
Lymphoma, T-Cell, Peripheral
Enrollment
224 pts
Location
China
Sponsor
Chipscreen Biosciences, Ltd.
NCT05549167 Phase 3
Recruiting
Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasop...
Condition
Juvenile Nasopharyngeal Angiofibroma
Enrollment
117 pts
Location
Russia
Sponsor
Federal Research Institute of
NCT06120400 Phase 3
Recruiting
Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs
Condition
Cardiovascular Diseases
Enrollment
65 pts
Location
United States
Sponsor
Penn State University
NCT06602271 Phase 3
Recruiting
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Condition
Postoperative Pain, Acute
Enrollment
320 pts
Location
United States
Sponsor
Ensysce Biosciences
NCT05937672 Phase 3
Recruiting
Cold Atmospheric Plasma Device Extension Study
Condition
Verruca Vulgaris
Enrollment
40 pts
Location
United States
Sponsor
Medical University of South Ca
NCT01954992 Phase 3
Recruiting
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
Condition
Metastatic Pancreatic Adenocarcinoma
Enrollment
480 pts
Location
United States
Sponsor
Eleison Pharmaceuticals LLC.
NCT04967989 Phase 3
Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
Condition
Glaucoma and Ocular Hypertension
Enrollment
790 pts
Location
United States, Canada
Sponsor
University of Pittsburgh
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07186803 Phase 3
Recruiting
AI and Safety in Laparoscopic Cholecystectomy: A Randomized Controlled Trial
Condition
Laparoscopic Cholecystectomy
Enrollment
70 pts
Location
Canada
Sponsor
University Health Network, Tor
NCT06343870 Phase 3
Recruiting
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
Condition
Menopause
Enrollment
140 pts
Location
Brazil
Sponsor
University of Sao Paulo Genera
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07018791 Phase 3
Recruiting
Art-Based Pain Assessment Tool in Patients With Temporomandibular Joint Disorder...
Condition
Temporomandibular Disorders (TMD)
Enrollment
70 pts
Location
Saudi Arabia
Sponsor
King Abdulaziz University
NCT06989697 Phase 3
Recruiting
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes
Condition
Type 2 Diabets Mellitus
Enrollment
80 pts
Location
South Korea
Sponsor
Seoul National University Bund
NCT04041479 Phase 3
Recruiting
Biomarker-guided rTMS for Treatment Resistant Depression
Condition
Treatment Resistant Depression
Enrollment
348 pts
Location
United States
Sponsor
Weill Medical College of Corne
NCT07132827 Phase 3
Recruiting
Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusiti...
Condition
Chronic Rhinosinusitis With Nasal Polyps
Enrollment
280 pts
Location
China
Sponsor
Guangdong Hengrui Pharmaceutic
NCT05182970 Phase 3
Recruiting
Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocard...
Condition
PreDiabetes
Enrollment
5,160 pts
Location
Sweden
Sponsor
Karolinska Institutet
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Partici...
Condition
Vitiligo
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Pfizer
NCT03903835 Phase 3
Recruiting
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
750 pts
Location
Belgium, Norway, Sweden
Sponsor
Karolinska Institutet
NCT05795140 Phase 3
Recruiting
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Parti...
Condition
Atypical Hemolytic Uremic Syndrome
Enrollment
125 pts
Location
Brazil, China, Czechia
Sponsor
Novartis Pharmaceuticals
NCT06243640 Phase 3
Recruiting
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
Condition
Generalized Anxiety Disorder
Enrollment
504 pts
Location
China
Sponsor
Beijing Union Pharmaceutical F